A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/713 (2006.01) A61K 31/337 (2006.01) A61K 45/06 (2006.01) A61K 47/42 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01) A61P 43/00 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2655355
Disclosed is use of an RPN2 gene expression inhibitor as a cancer cell proliferation inhibitor. If required, the cancer cell proliferation inhibitor may further contain an agent having an anti-cancer activity. If required, the cancer cell proliferation inhibitor may be administered together with atelocollagen. Also disclosed is an anti-cancer agent comprising the cancer cell proliferation inhibitor.
La présente invention concerne l'utilisation d'un inhibiteur de l'expression du gène RPN2 pour inhiber la prolifération des cellules cancéreuses. Si nécessaire, l'inhibiteur de la prolifération des cellules cancéreuses peut contenir en outre un agent ayant une activité anticancéreuse. Si nécessaire, l'inhibiteur de la prolifération des cellules cancéreuses peut être administré en même temps que de l'atélocollagène. L'invention concerne également un agent anticancéreux comprenant l'inhibiteur de la prolifération des cellules cancéreuses.
Honma Kimi
Kato Kikuya
Ochiya Takahiro
Ueda Yasuji
Dainippon Sumitomo Pharma Co. Ltd.
Japan As Represented By President Of National Cancer Center
Koken Co. Ltd.
Taisho Pharmaceutical Co. Ltd.
Torys Llp
LandOfFree
Use of rpn2 gene expression inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of rpn2 gene expression inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of rpn2 gene expression inhibitor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1626112